Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Molecular Templates stock
Learn how to easily invest in Molecular Templates stock.
Molecular Templates is a biotechnology business based in the US. Molecular Templates shares (MTEM) are listed on the NASDAQ and all prices are listed in US Dollars. Molecular Templates employs 224 staff and has a trailing 12-month revenue of around $35.1 million.
How to buy Molecular Templates stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – MTEM. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Commission-free trading
- Commission-free crypto
- No minimum account balance
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Molecular Templates stock price (NASDAQ: MTEM)Use our graph to track the performance of MTEM stocks over time.
Molecular Templates shares at a glance
|Latest market close||$0.53|
|52-week range||$0.31 - $3.64|
|50-day moving average||$0.48|
|200-day moving average||$0.89|
|Wall St. target price||$10.13|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.38|
Buy Molecular Templates stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Molecular Templates stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Molecular Templates price performance over time
|1 week (2023-01-23)||6.00%|
|1 month (2022-12-30)||61.59%|
|3 months (2022-10-28)||-15.87%|
|6 months (2022-07-29)||-37.05%|
|1 year (2022-01-28)||-82.09%|
|2 years (2021-01-29)||-95.37%|
|3 years (2020-01-30)||13.93|
|5 years (2018-01-29)||10.78|
Molecular Templates financials
|Revenue TTM||$35.1 million|
|Gross profit TTM||$-45,968,000|
|Return on assets TTM||-28.42%|
|Return on equity TTM||-212.21%|
|Market capitalisation||$29.2 million|
TTM: trailing 12 months
Molecular Templates share dividends
We're not expecting Molecular Templates to pay a dividend over the next 12 months.
Have Molecular Templates's shares ever split?
Molecular Templates's shares were split on a 1:11 basis on 1 August 2017. So if you had owned 11 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Molecular Templates shares – just the quantity. However, indirectly, the new 1000% higher share price could have impacted the market appetite for Molecular Templates shares which in turn could have impacted Molecular Templates's share price.
Molecular Templates share price volatility
Over the last 12 months, Molecular Templates's shares have ranged in value from as little as $0.31 up to $3.64. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Molecular Templates's is 1.2236. This would suggest that Molecular Templates's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Molecular Templates overview
Molecular Templates, Inc. , a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc.
Frequently asked questionsWhat percentage of Molecular Templates is owned by insiders or institutions?
Currently 4.874% of Molecular Templates shares are held by insiders and 74.365% by institutions. How many people work for Molecular Templates?
Latest data suggests 224 work at Molecular Templates. When does the fiscal year end for Molecular Templates?
Molecular Templates's fiscal year ends in December. Where is Molecular Templates based?
Molecular Templates's address is: 9301 Amberglen Boulevard, Austin, TX, United States, 78729 What is Molecular Templates's ISIN number?
Molecular Templates's international securities identification number is: US6085501095 What is Molecular Templates's CUSIP number?
Molecular Templates's Committee on Uniform Securities Identification Procedures number is: 885807107
More guides on Finder
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert